National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 7) (No. PB 89 of 2014) (Cth)

Case

PB 89 of 2014

National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 7)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 25 November 2014

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 7).

(2)        This Instrument may also be cited as PB 89 of 2014.

2          Commencement

This Instrument commences on 1 December 2014.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)

omit from the column headed “Claimed Price”:          5.11        substitute:             5.92

[2] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)

omit from the column headed “Claimed Price”:          7.91        substitute:             9.16

[3] Schedule 1, entry for Aspirin in the form Tablet 100 mg

(a)   omit from the column headed “Determined Price”:             1.10        substitute:             1.17

(b)   omit from the column headed “Claimed Price”:                  2.98        substitute:             3.05

[4] Schedule 1, omit entry for Baclofen

[5] Schedule 1, after entry for Bisacodyl

insert:

Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Bicor 28 16.56 18.99
Tablet containing bisoprolol fumarate 5 mg Oral Bicor 28 20.69 23.12
Tablet containing bisoprolol fumarate 10 mg Oral Bicor 28 25.87 28.36

[6] Schedule 1, entry for Bleomycin [Brands: Bleo 15K; Hospira Pty Limited]

omit from the column headed “Claimed Price”:          65.24     substitute:             40.28

[7] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

omit from the column headed “Claimed Price”:          2.73        substitute:             3.02

[8] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

omit from the column headed “Claimed Price”:          5.51        substitute:             5.81

[9] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

omit from the column headed “Claimed Price”:          13.87     substitute:             14.16

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

omit from the column headed “Claimed Price”:          16.49     substitute:             16.78

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

omit from the column headed “Claimed Price”:          14.25     substitute:             14.62

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

omit from the column headed “Claimed Price”:          16.72     substitute:             17.09

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

omit from the column headed “Claimed Price”:          17.89     substitute:             18.26

  1. Schedule 1, entry for Clarithromycin

omit from the column headed “Claimed Price”:          4.95        substitute:             5.63

  1. Schedule 1, entry for Clindamycin

(a)   omit from the column headed “Determined Price”:             10.78     substitute:             9.06

(b)   omit from the column headed “Claimed Price”:                  12.43     substitute:             10.44

  1. Schedule 1, entry for Diazepam

omit:

Tablet 2 mg Oral Valium 50 0.94 1.53

  1. Schedule 1, entry for Enalapril

omit:

Tablet containing enalapril maleate 5  mg Oral Renitec M 30 2.60 5.96

  1. Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10  mg

omit from the column headed “Claimed Price”:          7.63        substitute:             8.04

  1. Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20  mg

omit from the column headed “Claimed Price”:          8.81        substitute:             9.21

  1. Schedule 1, after entry for Glibenclamide

insert:

Gliclazide Tablet 60 mg (modified release) Oral Diamicron 60mg MR 60 6.73 8.31

  1. Schedule 1, entry for Glimepride in the form Tablet 1  mg

omit from the column headed “Claimed Price”:          3.12        substitute:             3.50

  1. Schedule 1, entry for Glimepride in the form Tablet 2  mg

omit from the column headed “Claimed Price”:          4.17        substitute:             4.49

  1. Schedule 1, entry for Glimepride in the form Tablet 3  mg

omit from the column headed “Claimed Price”:          4.77        substitute:             5.10

  1. Schedule 1, entry for Glimepride in the form Tablet 4  mg

omit from the column headed “Claimed Price”:          5.41        substitute:             5.74

  1. Schedule 1, entry for Indomethacin

(a)   omit from the column headed “Determined Price”:             2.43        substitute:             2.60

(b)   omit from the column headed “Claimed Price”:                  4.31        substitute:             4.48

  1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms
    and 7 inert tablets [Brand: Nordette 28]

omit from the column headed “Claimed Price”:          16.38     substitute:             18.81

  1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets [Brand: Triphasil 28]

omit from the column headed “Claimed Price”:          16.38     substitute:             18.81

  1. Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Prinivil 10]

omit from the column headed “Claimed Price”:          7.24        substitute:             7.61

  1. Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Prinivil 20]

omit from the column headed “Claimed Price”:          8.45        substitute:             8.81

  1. Schedule 1, entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL

omit from the column headed “Claimed Price”:          15.97     substitute:             18.15

  1. Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg

omit from the column headed “Claimed Price”:          6.18        substitute:             6.41

  1. Schedule 1, entry for Meloxicam in the form Capsule 15 mg

omit from the column headed “Claimed Price”:          8.18        substitute:             8.41

  1. Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

omit from the column headed “Claimed Price”:          6.18        substitute:             6.41

  1. Schedule 1, entry for Meloxicam in the form Tablet 15 mg

omit from the column headed “Claimed Price”:          8.18        substitute:             8.41

  1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg

omit from the column headed “Claimed Price”:          4.66        substitute:             5.47

  1. Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg

omit from the column headed “Claimed Price”:          6.56        substitute:             7.37

  1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]

omit from the column headed “Claimed Price”:          4.66        substitute:             5.47

  1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g

omit from the column headed “Claimed Price”:          7.00        substitute:             7.81

  1. Schedule 1, after entry for Metformin in the form Tablet containing metformin hydrochloride 1 g

insert:

Tablet (extended release) containing metformin hydrochloride 1 g Oral Diabex XR 1000 60 5.06 7.37

  1. Schedule 1, entry for Methyldopa

(a)   omit from the column headed “Determined Price”:             6.03        substitute:             8.18

(b)   omit from the column headed “Claimed Price”:                  8.89        substitute:             11.05

  1. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Brand: Betaloc]

omit from the column headed “Claimed Price”:          4.93        substitute:             5.25

  1. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Brand: Betaloc]

omit from the column headed “Claimed Price”:          5.55        substitute:             5.85

  1. Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)

omit from the column headed “Claimed Price”:          7.02        substitute:             7.39

  1. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg

omit from the column headed “Claimed Price”:          7.33        substitute:             8.41

  1. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)

omit from the column headed “Claimed Price”:          9.16        substitute:             9.52

  1. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg

omit from the column headed “Claimed Price”:          11.07     substitute:             12.14

  1. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)

omit from the column headed “Claimed Price”:          13.51     substitute:             13.87

  1. Schedule 1, entry for Norethisterone with Ethinyloestradiol in each of the forms: Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets; and Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets

omit from the column headed “Claimed Price”:          14.32     substitute:             16.75

  1. Schedule 1, after entry for Oxazepam in the form Tablet 30 mg

insert:

Paracetamol Tablet 665 mg (modified release) Oral Panadol Osteo 96 3.47 4.13

  1. Schedule 1, entry for Roxithromycin in each of the forms: Tablet 150 mg; and Tablet 300 mg

omit from the column headed “Claimed Price”:          3.17        substitute:             3.50

  1. Schedule 1, entry for Simvastatin

omit:

Tablet 5 mg Oral Zocor 30 1.28 2.64

  1. Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]

omit from the column headed “Claimed Price”:          3.13        substitute:             4.46

  1. Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]

omit from the column headed “Claimed Price”:          3.92        substitute:             5.25

  1. Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]

omit from the column headed “Claimed Price”:          5.04        substitute:             6.37

  1. Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]

omit from the column headed “Claimed Price”:          6.64        substitute:             7.97

  1. Schedule 1, entry for Temazepam

omit from the column headed “Claimed Price”:          2.23        substitute:             3.99

  1. Schedule 1, entry for Tinidazole

omit from the column headed “Claimed Price”:          5.96        substitute:             7.91

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0